Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7312 p235
14 August 2004


Society summary


Council agrees to end the role of honorary auditors of the Society

The Society’s Council has agreed to end the role of honorary auditor of the Society. The August Council meeting agreed that the role has been made obsolete by the demands of modern corporate governance and it will therefore not continue under the regulations that will supersede the Society’s Byelaws.

Making its decision, the Council expressed its appreciation for the commitment and contribution of all those members who have served as honorary auditors over the years. It was agreed to consider how members might assist the Council in fulfilling its responsibilities as guardian and trustee of the Society in the future.

The Council noted that audit is a legal requirement for the Society’s financial statements and that independent external financial auditors must scrutinise the Society’s annual accounts and sign as to whether they are a true and fair statement of the Society’s finances. In addition, the Society has an audit committee to provide oversight of its financial and non-financial control systems and of the standards of financial information employed by the Society. An independent firm of professional auditors also works with this committee and helps it carry out its role across the Society’s functions. The Society has in recent years reviewed its corporate governance to ensure that it meets best modern practice.

A Byelaw amendment is published in this week’s Journal (p241). Members have 60 days in which to comment on the proposed amendment.

Back to Top


©The Pharmaceutical Journal